Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series
1 other identifier
interventional
15
1 country
1
Brief Summary
A reliably effective treatment model for anorexia nervosa is yet to emerge. Recent clinical trials of psychological therapies over 20-30 sessions, have shown modest benefits. There is therefore a need to test new treatments to find more effective treatments. Clinical trials of Schema Therapy have shown low rates of dropout, which is often a problem in the treatment of anorexia nervosa. Treatment with Schema Therapy, for significantly longer than 20-30 sessions, has been shown to be effective for other complex mental health problems.This pilot study is therefore designed to pilot the use of individual Schema Therapy for people with Anorexia Nervosa (iST-AN). This study is a case series pilot study. The study will answer the principal research question: Does individual Schema mode Therapy, adapted for eating disorders, have the potential to improve symptoms, quality of life and weight in people with moderate-severe anorexia nervosa? It will also address secondary research questions: Can people with moderate-severe anorexia nervosa be recruited to, and kept engaged in, a study of iST-AN treatment? What is the ideal length of iST-AN treatment? What is the relationship between self-criticism, body shame, or unhelpful psychological 'modes' and clinical outcome? Fifteen people with moderate-severe Anorexia Nervosa will be recruited from referrals to a specialist eating disorders outpatient service. The study will deliver 65 sessions of Schema Therapy for anorexia nervosa (iST-AN), over a 24 month period, alongside any additional medical or dietetic management required. Standard outcome measures will be collected at 6 month intervals. The research team have expertise in eating disorders research, schema therapy for severe anorexia nervosa and are all members of the local clinical service. The study will take place over a 3 year period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2015
CompletedFirst Submitted
Initial submission to the registry
January 25, 2016
CompletedFirst Posted
Study publicly available on registry
January 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2018
CompletedSeptember 23, 2024
September 1, 2024
3.6 years
January 25, 2016
September 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Eating Disorders Examination questionnaire (EDE-Q)
A validated self-report measure of eating disorder symtpoms.
6 monthly
Secondary Outcomes (4)
Body Mass INdex (BMI)
6 monthly
WHO-QoL (bref)
6 monthly
Symptom Check List - 90
6 monthly
Global Assessment of Functioning (GAF)
6 monthly
Other Outcomes (3)
Forms of Self-Criticism/Self-Reassuring scale (FSCRS)
6 monthy
Body shame items of the Experiences of Shame Scale (ESS)
6 monthly
Schema Mode Inventory (SMI)
baseline and 24 months
Interventions
Psychological treatment using individual Schema-Mode Therapy for Anorexia Nervosa (iST-AN). A 60 session protocol will be used over an 18 month period, moving flexibly through five phases of treatment, guided by the psychological formulation: phase 1 - assessment, engagement \& stabilisation; phase 2 - developing trust \& understanding; phase 3 - developing awareness \& acceptance; phase 4 - testing change \& strengthening the healthy mode; phase 5 - consolidating change. A follow-up period of 6 months, with 5 further monthly sessions, will promote self-efficacy and further consolidate change. A total treatment package of 65 sessions will be offered, over 24 months.
Eligibility Criteria
You may qualify if:
- Diagnosis of AN or other DSM-V underweight eating disorder diagnosis AND
- yrs or over AND
- Moderate-severe, treatment resistant, comorbid, or chronic 3.1. BMI 13-15 OR 3.2. BMI 15-17.5 and ≥ 1 previous treatment episode for eating disorder OR 3.3. BMI 15-17.5 and a personality disorder diagnosis OR 3.4. BMI 15-17.5 and duration of eating disorder of \> 10 yrs
You may not qualify if:
- Diagnosis of psychotic disorder
- Diagnosis of alcohol or drug dependence
- Diagnosis of learning disability or autistic spectrum disorder
- English language skills not adequate for therapy
- Previous treatment with Schema Mode Therapy
- Unable to make realistic commitment to attend weekly appointments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Lothianlead
Study Sites (1)
Royal Edinburgh Hospital
Edinburgh, EH10 5HF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2016
First Posted
January 28, 2016
Study Start
January 25, 2015
Primary Completion
August 31, 2018
Study Completion
August 31, 2018
Last Updated
September 23, 2024
Record last verified: 2024-09